Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study

被引：27

作者：

Cassaniti, Irene ^{[1
,2
]}

Bergami, Federica ^{[1
]}

Percivalle, Elena ^{[1
]}

Gabanti, Elisa ^{[1
]}

Sammartino, Jose Camilla ^{[1
]}

Ferrari, Alessandro ^{[1
]}

Adzasehoun, Kodjo Messan Guy ^{[1
]}

Zavaglio, Federica ^{[1
]}

Zelini, Paola ^{[3
]}

Comolli, Giuditta ^{[1
,4
]}

Sarasini, Antonella ^{[1
]}

Piralla, Antonio ^{[1
]}

Ricciardi, Alessandra ^{[5
]}

Zuccaro, Valentina ^{[5
]}

Maggi, Fabrizio ^{[6
,7
]}

Novazzi, Federica ^{[7
]}

Simonelli, Luca ^{[8
]}

Varani, Luca ^{[8
]}

Lilleri, Daniele ^{[1
]}

Baldanti, Fausto ^{[1
,2
]}

机构：

[1] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy

[2] Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Pavia, Italy

[3] Fdn IRCCS Policlin San Matteo, Obstet & Gynaecol, Pavia, Italy

[4] Fdn IRCCS Policlin San Matteo, Lab Biochem Biotechnol & Adv Diagnost, Pavia, Italy

[5] Fdn IRCCS Policlin San Matteo, Infect Dis 1, Pavia, Italy

[6] ASST Sette Laghi, Lab Microbiol, Varese, Italy

[7] Univ Insubria, Dept Med & Surg, Varese, Italy

[8] Inst Res Biomed, Bellinzona, Switzerland

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2022年 / 28卷 / 02期

关键词：

Antibody response; mRNA vaccine; SARS-CoV-2; T-cell response; Viral variants;

D O I：

10.1016/j.cmi.2021.09.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Objectives: To assess the humoral and cell-mediated response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicited by the mRNA BNT162b2 vaccine in SARS-CoV-2-experienced and -naive subjects against a reference strain and SARS-CoV-2 variants. Methods: The humoral response (including neutralizing antibodies) and T-cell-mediated response elicited by BNT162b2 vaccine in 145 healthcare workers (both naive and positive for previous SARS-CoV-2 infection) were evaluated. In a subset of subjects, the effect of SARS-CoV-2 variants on antibody level and cell-mediated response was also investigated. Results: Overall, 125/127 naive subjects (98.4%) developed both neutralizing antibodies and specific T cells after the second dose of vaccine. Moreover, the antibody and T-cell responses were effective against viral variants since SARS-CoV-2 NT Abs were still detectable in 55/68 (80.9%) and 25/29 (86.2%) naive subjects when sera were challenged against beta and delta variants, respectively. T-cell response was less affected, with no significant difference in the frequency of responders (p 0.369). Of note, two doses of vaccine were able to elicit sustained neutralizing antibody activity against all the SARS-CoV-2 variants tested in SARS-CoV-2-experienced subjects. Conclusions: BNT162b2 vaccine elicited a sustained humoral and cell-mediated response in immunocompetent subjects after two-dose administration of the vaccine, and the response seemed to be less affected by SARS-CoV-2 variants, the only exceptions being the beta and delta variants. Increased immunogenicity, also against SARS-CoV-2 variant strains, was observed in SARS-CoV-2-experienced subjects. These results suggest that triple exposure to SARS-CoV-2 antigens might be proposed as valuable strategy for vaccination campaigns. (C) 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

引用

页码：301.e1 / 301.e8

页数：8

共 33 条

[1] Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021 [J].

Abu Jabal, Kamal ;

Ben-Amram, Hila ;

Beiruti, Karine ;

Batheesh, Yunis ;

Sussan, Christian ;

Zarka, Salman ;

Edelstein, Michael .

EUROSURVEILLANCE, 2021, 26 (06)

[2] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].

Anderson, E. J. ;

Rouphael, N. G. ;

Widge, A. T. ;

Jackson, L. A. ;

Roberts, P. C. ;

Makhene, M. ;

Chappell, J. D. ;

Denison, M. R. ;

Stevens, L. J. ;

Pruijssers, A. J. ;

McDermott, A. B. ;

Flach, B. ;

Lin, B. C. ;

Doria-Rose, N. A. ;

O'Dell, S. ;

Schmidt, S. D. ;

Corbett, K. S. ;

Swanson, P. A., II ;

Padilla, M. ;

Neuzil, K. M. ;

Bennett, H. ;

Leav, B. ;

Makowski, M. ;

Albert, J. ;

Cross, K. ;

Edara, V. V. ;

Floyd, K. ;

Suthar, M. S. ;

Martinez, D. R. ;

Baric, R. ;

Buchanan, W. ;

Luke, C. J. ;

Phadke, V. K. ;

Rostad, C. A. ;

Ledgerwood, J. E. ;

Graham, B. S. ;

Beigel, J. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438

[3] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[4] Clq binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human ClqA chain in a sequence independent manner [J].

Bradley, AJ ;

Brooks, DE ;

Norris-Jones, R ;

Devine, DV .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1418 (01) :19-30

[5]

Bradley T, ANTIBODY RESPONSES B, V2021

[6] SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay [J].

Cassaniti, Irene ;

Percivalle, Elena ;

Bergami, Federica ;

Piralla, Antonio ;

Comolli, Giuditta ;

Bruno, Raffaele ;

Vecchia, Marco ;

Sambo, Margherita ;

Colaneri, Marta ;

Zuccaro, Valentina ;

Benazzo, Marco ;

Robotti, Carlo ;

Calastri, Anna ;

Maiorano, Eugenia ;

Ferrari, Alessandro ;

Cambie, Giuseppe ;

Baldanti, Fausto .

CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (07) :1029-1034

[7] Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection [J].

Dan, Jennifer M. ;

Mateus, Jose ;

Kato, Yu ;

Hastie, Kathryn M. ;

Yu, Esther Dawen ;

Faliti, Caterina E. ;

Grifoni, Alba ;

Ramirez, Sydney, I ;

Haupt, Sonya ;

Frazier, April ;

Nakao, Catherine ;

Rayaprolu, Vamseedhar ;

Rawlings, Stephen A. ;

Peters, Bjoern ;

Krammer, Florian ;

Simon, Viviana ;

Saphire, Erica Ollmann ;

Smith, Davey M. ;

Weiskopf, Daniela ;

Sette, Alessandro ;

Crotty, Shane .

SCIENCE, 2021, 371 (6529) :587-+

[8] Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England [J].

Davies, Nicholas G. ;

Abbott, Sam ;

Barnard, Rosanna C. ;

Jarvis, Christopher, I ;

Kucharski, Adam J. ;

Munday, James D. ;

Pearson, Carl A. B. ;

Russell, Timothy W. ;

Tully, Damien C. ;

Washburne, Alex D. ;

Wenseleers, Tom ;

Gimma, Amy ;

Waites, William ;

Wong, Kerry L. M. ;

van Zandvoort, Kevin ;

Silverman, Justin D. ;

Diaz-Ordaz, Karla ;

Keogh, Ruth ;

Eggo, Rosalind M. ;

Funk, Sebastian ;

Jit, Mark ;

Atkins, Katherine E. ;

Edmunds, W. John .

SCIENCE, 2021, 372 (6538) :149-+

[9] COVID-19-neutralizing antibodies predict disease severity and survival [J].

Garcia-Beltran, Wilfredo F. ;

Lam, Evan C. ;

Astudillo, Michael G. ;

Yang, Diane ;

Miller, Tyler E. ;

Feldman, Jared ;

Hauser, Blake M. ;

Caradonna, Timothy M. ;

Clayton, Kiera L. ;

Nitido, Adam D. ;

Murali, Mandakolathur R. ;

Alter, Galit ;

Charles, Richelle C. ;

Dighe, Anand ;

Branda, John A. ;

Lennerz, Jochen K. ;

Lingwood, Daniel ;

Schmidt, Aaron G. ;

Iafrate, A. John ;

Balazs, Alejandro B. .

CELL, 2021, 184 (02) :476-+

[10]

Greaney AJ, MUTATIONAL ESCAPE PO, V2021

← 1 2 3 4 →